-
1
-
-
0037129380
-
Nonalcoholic fatty liver disease.
-
[PMID: 11961152 DOI: 10.1056/NEJMra011775]
-
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346: 1221-1231 [PMID: 11961152 DOI: 10.1056/NEJMra011775]
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
2
-
-
3042711985
-
Liver echogenicity: measurement or visual grading
-
PMID:15249074 DOI: 10.1016/j.compmedimag.2004.03.003
-
Vehmas T, Kaukiainen A, Luoma K, Lohman M, Nurminen M, Taskinen H. Liver echogenicity: measurement or visual grading? Comput Med Imaging Graph 2004; 28: 289-293 [PMID:15249074 DOI: 10.1016/j.compmedimag.2004.03.003]
-
(2004)
Comput Med Imaging Graph
, vol.28
, pp. 289-293
-
-
Vehmas, T.1
Kaukiainen, A.2
Luoma, K.3
Lohman, M.4
Nurminen, M.5
Taskinen, H.6
-
3
-
-
61649104775
-
Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: prevalence and relationships with hemodynamic alterations detected with doppler sonography.
-
[DOI: 10.1016/j.jus.2008.12.002]
-
Gaiani S, Avogaro A, Bombonato GC, Bolognesi M, Amor F, Vigili de Kreutzenberg S, Guarneri G, Sacerdoti DF. Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: prevalence and relationships with hemodynamic alterations detected with doppler sonography. J Ultrasound 2009; 12: 1-5 [DOI: 10.1016/j.jus.2008.12.002]
-
(2009)
J Ultrasound
, vol.12
, pp. 1-5
-
-
Gaiani, S.1
Avogaro, A.2
Bombonato, G.C.3
Bolognesi, M.4
Amor, F.5
De Kreutzenberg, V.S.6
Guarneri, G.7
Sacerdoti, D.F.8
-
4
-
-
0035991444
-
In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases.
-
[PMID: 12076862 DOI: 10.1016/ S0168-8278(02)00073-9]
-
Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 2002; 37: 56-62 [PMID: 12076862 DOI: 10.1016/ S0168-8278(02)00073-9]
-
(2002)
J Hepatol
, vol.37
, pp. 56-62
-
-
Seki, S.1
Kitada, T.2
Yamada, T.3
Sakaguchi, H.4
Nakatani, K.5
Wakasa, K.6
-
5
-
-
0034950652
-
Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.
-
[PMID: 11438497 DOI: 10.1053/gast.2001.25540]
-
Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100 [PMID: 11438497 DOI: 10.1053/gast.2001.25540]
-
(2001)
Gastroenterology
, vol.121
, pp. 91-100
-
-
Dixon, J.B.1
Bhathal, P.S.2
O'brien, P.E.3
-
6
-
-
4143100133
-
Non-alcoholic steatohepatitis in type 2 diabetes mellitus.
-
[PMID: 15242486 DOI: 10.1111/ j.1440-1746.2004.03312.x]
-
Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, Patel N, Madan A, Amarapurkar A. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854-858 [PMID: 15242486 DOI: 10.1111/ j.1440-1746.2004.03312.x]
-
(2004)
J Gastroenterol Hepatol
, vol.19
, pp. 854-858
-
-
Gupte, P.1
Amarapurkar, D.2
Agal, S.3
Baijal, R.4
Kulshrestha, P.5
Pramanik, S.6
Patel, N.7
Madan, A.8
Amarapurkar, A.9
-
7
-
-
78651297599
-
Visceral adiposity as a cause of some cardiovascular disorders.
-
Cacciapuoti F. Visceral adiposity as a cause of some cardiovascular disorders. Old and new adipocytokines. Obes Metab 2010; 6: 35-46
-
(2010)
Old and new adipocytokines. Obes Metab
, vol.6
, pp. 35-46
-
-
Cacciapuoti, F.1
-
9
-
-
6944227798
-
Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
-
[PMID: 15505132 DOI: 10.1001/archinte.164.19.2169]
-
Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 164: 2169-2175 [PMID: 15505132 DOI: 10.1001/archinte.164.19.2169]
-
(2004)
Arch Intern Med
, vol.164
, pp. 2169-2175
-
-
Kim, H.J.1
Kim, H.J.2
Lee, K.E.3
Kim, D.J.4
Kim, S.K.5
Ahn, C.W.6
Lim, S.K.7
Kim, K.R.8
Lee, H.C.9
Huh, K.B.10
Cha, B.S.11
-
10
-
-
84986946657
-
The relationship between serum transaminase activities and fatty liver in children with simple obesity.
-
[PMID: 8533591 DOI: 10.1111/j.1442-200X.1995. tb03389.x]
-
Noguchi H, Tazawa Y, Nishinomiya F, Takada G. The relationship between serum transaminase activities and fatty liver in children with simple obesity. Acta Paediatr Jpn 1995; 37: 621-625 [PMID: 8533591 DOI: 10.1111/j.1442-200X.1995. tb03389.x]
-
(1995)
Acta Paediatr Jpn
, vol.37
, pp. 621-625
-
-
Noguchi, H.1
Tazawa, Y.2
Nishinomiya, F.3
Takada, G.4
-
11
-
-
3142670354
-
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial.
-
[PMID: 15225167 DOI: 10.1111/j.1365-2036.2004.02025.x]
-
Nair S, Diehl AM, Wiseman M, Farr GH, Perrillo RP. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 2004; 20: 23-28 [PMID: 15225167 DOI: 10.1111/j.1365-2036.2004.02025.x]
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 23-28
-
-
Nair, S.1
Diehl, A.M.2
Wiseman, M.3
Farr, G.H.4
Perrillo, R.P.5
-
12
-
-
3242745192
-
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.
-
[PMID: 15277403 DOI: 10.2337/diabetes.53.8.2169]
-
Tiikkainen M, Häkkinen AM, Korsheninnikova E, Nyman T, Mäkimattila S, Yki-Järvinen H. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 2004; 53: 2169-2176 [PMID: 15277403 DOI: 10.2337/diabetes.53.8.2169]
-
(2004)
Diabetes
, vol.53
, pp. 2169-2176
-
-
Tiikkainen, M.1
Häkkinen, A.M.2
Korsheninnikova, E.3
Nyman, T.4
Mäkimattila, S.5
Yki-järvinen, H.6
-
13
-
-
78651473467
-
Efficacy of longterm ezetimibe therapy in patients with nonalcoholic fatty liver disease.
-
[PMID: 20658156 DOI: 10.1007/s00535-010-0291-8]
-
Park H, Shima T, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K, Itoh Y, Yoshikawa T, Fukui M, Hasegawa G, Nakamura N, Ohta M, Obayashi H, Okanoue T. Efficacy of longterm ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol 2011; 46: 101-107 [PMID: 20658156 DOI: 10.1007/s00535-010-0291-8]
-
(2011)
J Gastroenterol
, vol.46
, pp. 101-107
-
-
Park, H.1
Shima, T.2
Yamaguchi, K.3
Mitsuyoshi, H.4
Minami, M.5
Yasui, K.6
Itoh, Y.7
Yoshikawa, T.8
Fukui, M.9
Hasegawa, G.10
Nakamura, N.11
Ohta, M.12
Obayashi, H.13
Okanoue, T.14
-
14
-
-
0034859659
-
Silymarin: a review of its clinical properties in the management of hepatic disorders.
-
[PMID: 11520257 DOI: 10.2165/00063030-20 0115070-00005]
-
Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001; 15: 465-489 [PMID: 11520257 DOI: 10.2165/00063030-20 0115070-00005]
-
(2001)
BioDrugs
, vol.15
, pp. 465-489
-
-
Wellington, K.1
Jarvis, B.2
-
15
-
-
0030907984
-
Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients.
-
[PMID: 9126802 DOI: 10.1016/S0168-8278(97)80255-3]
-
Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C, Zilli M. Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol 1997; 26: 871-879 [PMID: 9126802 DOI: 10.1016/S0168-8278(97)80255-3]
-
(1997)
J Hepatol
, vol.26
, pp. 871-879
-
-
Velussi, M.1
Cernigoi, A.M.2
De Monte, A.3
Dapas, F.4
Caffau, C.5
Zilli, M.6
-
17
-
-
33646770979
-
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations.
-
[PMID:16698763 DOI: 10.1136/gut.2006.091967]
-
Federico A, Trappoliere M, Tuccillo C, de Sio I, Di Leva A, Del Vecchio Blanco C, Loguercio C. A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations. Gut 2006; 55: 901-902 [PMID:16698763 DOI: 10.1136/gut.2006.091967]
-
(2006)
Gut
, vol.55
, pp. 901-902
-
-
Federico, A.1
Trappoliere, M.2
Tuccillo, C.3
de Sio, I.4
Di Leva, A.5
Vecchio Blanco, D.C.6
Loguercio, C.7
-
18
-
-
84879185607
-
Comparison of therapeutic effects of Silymarin and Vitamin E in nonalcoholic fatty liver disease: results of an open-label
-
propective, randomized study. JJNPP
-
Hasjiani E, Hasahemi SJ. Comparison of therapeutic effects of Silymarin and Vitamin E in nonalcoholic fatty liver disease: results of an open-label, propective, randomized study. JJNPP 2009; 4: 8-14
-
(2009)
, vol.4
, pp. 8-14
-
-
Hasjiani, E.1
Hasahemi, S.J.2
-
19
-
-
0021813187
-
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
-
[PMID: 3899825 DOI: 10.1007/BF00280883]
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419 [PMID: 3899825 DOI: 10.1007/BF00280883]
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
20
-
-
63849332359
-
Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis.
-
[PMID: 19304694 DOI: 10.2214/AJR.07.4016]
-
Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z, Oren R. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 2009; 192: 909-914 [PMID: 19304694 DOI: 10.2214/AJR.07.4016]
-
(2009)
AJR Am J Roentgenol
, vol.192
, pp. 909-914
-
-
Webb, M.1
Yeshua, H.2
Zelber-sagi, S.3
Santo, E.4
Brazowski, E.5
Halpern, Z.6
Oren, R.7
-
21
-
-
0036090972
-
Nonalcoholic fatty liver disease
-
[PMID: 12016429 DOI: 10.1053/gast.2002.33573]
-
Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 1649-1657 [PMID: 12016429 DOI: 10.1053/gast.2002.33573]
-
(2002)
Gastroenterology
, vol.122
, pp. 1649-1657
-
-
Clark, J.M.1
Brancati, F.L.2
Diehl, A.M.3
-
22
-
-
33748301260
-
Global challenges in liver disease
-
PMID: 16941687 DOI: 10.1002/hep.21347
-
Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-526 [PMID: 16941687 DOI: 10.1002/hep.21347]
-
(2006)
Hepatology
, vol.44
, pp. 521-526
-
-
Williams, R.1
-
23
-
-
21344449292
-
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
-
[PMID: 15895401 DOI: 10.1002/ hep.20734]
-
Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52 [PMID: 15895401 DOI: 10.1002/ hep.20734]
-
(2005)
Hepatology
, vol.42
, pp. 44-52
-
-
Bedogni, G.1
Miglioli, L.2
Masutti, F.3
Tiribelli, C.4
Marchesini, G.5
Bellentani, S.6
-
24
-
-
0035864845
-
Liver biopsy.
-
[PMID: 11172192 DOI: 10.1056/ NEJM200102153440706]
-
Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500 [PMID: 11172192 DOI: 10.1056/ NEJM200102153440706]
-
(2001)
N Engl J Med
, vol.344
, pp. 495-500
-
-
Bravo, A.A.1
Sheth, S.G.2
Chopra, S.3
-
25
-
-
0018385724
-
Comparison of the histological lesions in tissue specimens taken from the right and left lobe of the liver in alcoholic liver disease (author's transl).
-
[PMID: 456818]
-
Labayle D, Chaput JC, Albuisson F, Buffet C, Martin E, Etienne JP. Comparison of the histological lesions in tissue specimens taken from the right and left lobe of the liver in alcoholic liver disease (author's transl). Gastroenterol Clin Biol 1979; 3: 235-240 [PMID: 456818]
-
(1979)
Gastroenterol Clin Biol
, vol.3
, pp. 235-240
-
-
Labayle, D.1
Chaput, J.C.2
Albuisson, F.3
Buffet, C.4
Martin, E.5
Etienne, J.P.6
-
26
-
-
20444443042
-
Sampling variability of liver biopsy in nonalcoholic fatty liver disease.
-
[PMID: 15940625 DOI: 10.1053/ j.gastro.2005.03.084]
-
Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906 [PMID: 15940625 DOI: 10.1053/ j.gastro.2005.03.084]
-
(2005)
Gastroenterology
, vol.128
, pp. 1898-1906
-
-
Ratziu, V.1
Charlotte, F.2
Heurtier, A.3
Gombert, S.4
Giral, P.5
Bruckert, E.6
Grimaldi, A.7
Capron, F.8
Poynard, T.9
-
27
-
-
0036829092
-
AGA technical review on nonalcoholic fatty liver disease.
-
[PMID: 12404245 DOI: 10.1053/gast.2002.36572]
-
Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725 [PMID: 12404245 DOI: 10.1053/gast.2002.36572]
-
(2002)
Gastroenterology
, vol.123
, pp. 1705-1725
-
-
Sanyal, A.J.1
-
28
-
-
18244367137
-
Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study.
-
[PMID: 15731489 DOI: 10.1161/01. ATV.0000160613.57985.18]
-
Brea A, Mosquera D, Martín E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005; 25: 1045-1050 [PMID: 15731489 DOI: 10.1161/01. ATV.0000160613.57985.18]
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1045-1050
-
-
Brea, A.1
Mosquera, D.2
Martín, E.3
Arizti, A.4
Cordero, J.L.5
Ros, E.6
-
29
-
-
0033231294
-
Association of nonalcoholic fatty liver disease with insulin resistance.
-
[PMID: 10569299 DOI: 10.1016/ S0002-9343(99)00271-5]
-
Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-455 [PMID: 10569299 DOI: 10.1016/ S0002-9343(99)00271-5]
-
(1999)
Am J Med
, vol.107
, pp. 450-455
-
-
Marchesini, G.1
Brizi, M.2
Morselli-labate, A.M.3
Bianchi, G.4
Bugianesi, E.5
Mccullough, A.J.6
Forlani, G.7
Melchionda, N.8
-
30
-
-
34247647418
-
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.
-
[PMID: 17461452]
-
Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13: 1579-1584 [PMID: 17461452]
-
(2007)
World J Gastroenterol
, vol.13
, pp. 1579-1584
-
-
Hamaguchi, M.1
Kojima, T.2
Takeda, N.3
Nagata, C.4
Takeda, J.5
Sarui, H.6
Kawahito, Y.7
Yoshida, N.8
Suetsugu, A.9
Kato, T.10
Okuda, J.11
Ida, K.12
Yoshikawa, T.13
-
31
-
-
18244364864
-
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.
-
[PMID: 11826411 DOI: 10.1053/jhep.2002.30692]
-
Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379 [PMID: 11826411 DOI: 10.1053/jhep.2002.30692]
-
(2002)
Hepatology
, vol.35
, pp. 373-379
-
-
Chitturi, S.1
Abeygunasekera, S.2
Farrell, G.C.3
Holmes-walker, J.4
Hui, J.M.5
Fung, C.6
Karim, R.7
Lin, R.8
Samarasinghe, D.9
Liddle, C.10
Weltman, M.11
George, J.12
-
32
-
-
4344628553
-
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease.
-
[PMID: 15331065 DOI: 10.1016/j.cld.2004.04.006]
-
Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8: 575-594 [PMID: 15331065 DOI: 10.1016/j.cld.2004.04.006]
-
(2004)
Clin Liver Dis
, vol.8
, pp. 575-594
-
-
Choudhury, J.1
Sanyal, A.J.2
-
33
-
-
0033846558
-
Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes.
-
[PMID: 10990076 DOI: 10.1007/s001250051481]
-
Bernard S, Touzet S, Personne I, Lapras V, Bondon PJ, Berthezène F, Moulin P. Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia 2000; 43: 995-999 [PMID: 10990076 DOI: 10.1007/s001250051481]
-
(2000)
Diabetologia
, vol.43
, pp. 995-999
-
-
Bernard, S.1
Touzet, S.2
Personne, I.3
Lapras, V.4
Bondon, P.J.5
Berthezène, F.6
Moulin, P.7
-
34
-
-
30044437451
-
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis.
-
[PMID: 16375767 DOI: 10.1186/1476-5926-4-10]
-
Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y, Munteanu M, Mercadier A, Manns M, Albrecht J. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005; 4: 10 [PMID: 16375767 DOI: 10.1186/1476-5926-4-10]
-
(2005)
Comp Hepatol
, vol.4
, pp. 10
-
-
Poynard, T.1
Ratziu, V.2
Naveau, S.3
Thabut, D.4
Charlotte, F.5
Messous, D.6
Capron, D.7
Abella, A.8
Massard, J.9
Ngo, Y.10
Munteanu, M.11
Mercadier, A.12
Manns, M.13
Albrecht, J.14
-
35
-
-
0019152816
-
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
-
[PMID: 7382552]
-
Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438 [PMID: 7382552]
-
(1980)
Mayo Clin Proc
, vol.55
, pp. 434-438
-
-
Ludwig, J.1
Viggiano, T.R.2
Mcgill, D.B.3
Oh, B.J.4
-
36
-
-
0032695030
-
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
-
[PMID: 10573511 DOI: 10.1002/hep.510300604]
-
Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362 [PMID: 10573511 DOI: 10.1002/hep.510300604]
-
(1999)
Hepatology
, vol.30
, pp. 1356-1362
-
-
Angulo, P.1
Keach, J.C.2
Batts, K.P.3
Lindor, K.D.4
-
37
-
-
0037109597
-
Milk thistle for the treatment of liver disease: a systematic review and meta-analysis.
-
[PMID: 12427501 DOI: 10.1016/S0002-9343(02)01244-5]
-
Jacobs BP, Dennehy C, Ramirez G, Sapp J, Lawrence VA. Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. Am J Med 2002; 113: 506-515 [PMID: 12427501 DOI: 10.1016/S0002-9343(02)01244-5]
-
(2002)
Am J Med
, vol.113
, pp. 506-515
-
-
Jacobs, B.P.1
Dennehy, C.2
Ramirez, G.3
Sapp, J.4
Lawrence, V.A.5
-
38
-
-
0042265627
-
Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.
-
[PMID: 12883485 DOI: 10.1053/jhep.2003.50316]
-
Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003; 38: 413-419 [PMID: 12883485 DOI: 10.1053/jhep.2003.50316]
-
(2003)
Hepatology
, vol.38
, pp. 413-419
-
-
Kugelmas, M.1
Hill, D.B.2
Vivian, B.3
Marsano, L.4
Mcclain, C.J.5
-
39
-
-
27444432013
-
Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study.
-
[PMID: 16203871 DOI: 10.1161/01. HYP.0000185688.81320.4d]
-
Stranges S, Trevisan M, Dorn JM, Dmochowski J, Donahue RP. Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study. Hypertension 2005; 46: 1186-1193 [PMID: 16203871 DOI: 10.1161/01. HYP.0000185688.81320.4d]
-
(2005)
Hypertension
, vol.46
, pp. 1186-1193
-
-
Stranges, S.1
Trevisan, M.2
Dorn, J.M.3
Dmochowski, J.4
Donahue, R.P.5
-
41
-
-
84856274286
-
Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method.
-
[PMID: 22016092 DOI: 10.1038/oby.2011.302]
-
Xia MF, Yan HM, He WY, Li XM, Li CL, Yao XZ, Li RK, Zeng MS, Gao X. Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity (Silver Spring) 2012; 20: 444-452 [PMID: 22016092 DOI: 10.1038/oby.2011.302]
-
(2012)
Obesity (Silver Spring)
, vol.20
, pp. 444-452
-
-
Xia, M.F.1
Yan, H.M.2
He, W.Y.3
Li, X.M.4
Li, C.L.5
Yao, X.Z.6
Li, R.K.7
Zeng, M.S.8
Gao, X.9
-
42
-
-
0030047836
-
Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes.
-
[PMID: 8655663]
-
Osawa H, Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 1996; 24: 25-29 [PMID: 8655663]
-
(1996)
J Clin Ultrasound
, vol.24
, pp. 25-29
-
-
Osawa, H.1
Mori, Y.2
-
43
-
-
84879163714
-
A pratical index for ultrasonographic quantification of liver steatosis.
-
Boston, MA: The 58th Annual Meeting of the American Association for the study of liver disease
-
Webb M, Hanny Yeshua H, Zelber-Sagie S, Santo M, Barawoski E, Katz R, Halpern Z, Oren R. A pratical index for ultrasonographic quantification of liver steatosis. Boston, MA: The 58th Annual Meeting of the American Association for the study of liver disease, 2007
-
(2007)
-
-
Webb, M.1
Hanny Yeshua, H.2
Zelber-sagie, S.3
Santo, M.4
Barawoski, E.5
Katz, R.6
Halpern, Z.7
Oren, R.8
-
44
-
-
0036911218
-
One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation.
-
[PMID: 12474149]
-
Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002; 8: 1114-1122 [PMID: 12474149]
-
(2002)
Liver Transpl
, vol.8
, pp. 1114-1122
-
-
Ryan, C.K.1
Johnson, L.A.2
Germin, B.I.3
Marcos, A.4
-
45
-
-
78049500469
-
Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.
-
[PMID: 20939106]
-
Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16: 4784-4791 [PMID: 20939106]
-
(2010)
World J Gastroenterol
, vol.16
, pp. 4784-4791
-
-
Fierbinteanu-braticevici, C.1
Dina, I.2
Petrisor, A.3
Tribus, L.4
Negreanu, L.5
Carstoiu, C.6
-
46
-
-
0032008339
-
Milk thistle (Silybum marianum) for the therapy of liver disease.
-
[PMID: 9468229 DOI: 10.1111/ j.1572-0241.1998.00139.x]
-
Flora K, Hahn M, Rosen H, Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998; 93: 139-143 [PMID: 9468229 DOI: 10.1111/ j.1572-0241.1998.00139.x]
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 139-143
-
-
Flora, K.1
Hahn, M.2
Rosen, H.3
Benner, K.4
-
47
-
-
34547839674
-
The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study.
-
[PMID: 17410454 DOI: 10.1007/ s10620-006-9703-2]
-
Loguercio C, Federico A, Trappoliere M, Tuccillo C, de Sio I, Di Leva A, Niosi M, D'Auria MV, Capasso R, Del Vecchio Blanco C.The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci 2007; 52: 2387-2395 [PMID: 17410454 DOI: 10.1007/ s10620-006-9703-2]
-
(2007)
Dig Dis Sci
, vol.52
, pp. 2387-2395
-
-
Loguercio, C.1
Federico, A.2
Trappoliere, M.3
Tuccillo, C.4
de Sio, I.5
Di Leva, A.6
Niosi, M.7
D'auria, M.V.8
Capasso, R.9
Vecchio Blanco, D.C.10
|